Tilray fell 5.9% in early trading on Monday, partially giving back gains.

In the early trading on Monday, the US stock market, the cannabis stock Tilray fell by 5.9%, partially giving back the 44% gain from last Friday. The stock surged last week on news that the US President Trump instructed federal agencies to reclassify cannabis from a Schedule I controlled substance to a more loosely regulated Schedule III.